PPARG as therapeutic target for antifibrotic therapy

dc.contributor.authorGhallab, Ahmed
dc.contributor.authorSeddek, Abdellatief
dc.date.accessioned2020-10-06T13:00:54Z
dc.date.available2020-10-06T13:00:54Z
dc.date.issued2020-02-28
dc.identifier.citationhttps://doi.org/10.17179/excli2020-1136de
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/39762
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21654
dc.language.isoen
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmundde
dc.relation.ispartofseriesEXCLI Journal;Vol. 19. 2020, p 227-229
dc.subjectPPARGen
dc.subjectTherapeutic targeten
dc.subjectAntifibrotic therapyen
dc.subject.ddc610
dc.titlePPARG as therapeutic target for antifibrotic therapyen
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1
eldorado.secondarypublicationtrue

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ghallab_28022020_proof.pdf
Size:
76.63 KB
Format:
Adobe Portable Document Format
Description:
DNB
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.85 KB
Format:
Item-specific license agreed upon to submission
Description: